NYSE:MMS - Maximus Stock Price, Price Target & More

Get Started

$62.24 +0.29 (+0.47 %)

(As of 05/20/2018 04:00 PM ET)

Previous Close$62.24

Today's Range$62.01 - $62.57

52-Week Range$58.58 - $72.71

Volume613,281 shs

Average Volume488,986 shs

Market Capitalization$4.06 billion

P/E Ratio20.54

Dividend Yield0.29%

Beta1.13

About Maximus (NYSE:MMS)

MAXIMUS, Inc. provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews. Its services include health insurance exchange customer contact center operations and support; health insurance program eligibility and enrollment; beneficiary outreach and education; application assistance and independent health plan enrollment counseling; premium payment processing and administration; eHealth solutions; independent disability, long-term sick, and health assessments; occupational health clinical assessments; and specialized program consulting services. The company's U.S. Federal Services segment offers services, including centralized customer contact centers and support services; documents and records management; and case management, citizen engagement, and consumer education; independent medical reviews and worker's compensation benefit appeals; health benefit appeals; eligibility appeals; modernization of systems and IT infrastructure; infrastructure operations and support; software development, operations, and management; and data analytics. Its Human Services segment provides national, state, and local human services agencies with various BPS and related consulting services for welfare-to-work, child support, and higher education; and management tools and professional consulting, program consulting, and tax credit and employer services. MAXIMUS, Inc. was founded in 1975 and is headquartered in Reston, Virginia.

Receive MMS News and Ratings via Email

Sign-up to receive the latest news and ratings for MMS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified

Sub-IndustryData Processing & Outsourced Services

SectorBusiness Services

SymbolNYSE:MMS

CUSIP57793310

Webwww.maximus.com

Phone703-251-8500

Debt

Debt-to-Equity RatioN/A

Current Ratio2.72

Quick Ratio2.72

Price-To-Earnings

Trailing P/E Ratio20.54

Forward P/E Ratio19.21

P/E Growth2.4

Sales & Book Value

Annual Sales$2.45 billion

Price / Sales1.66

Cash Flow$4.1355 per share

Price / Cash15.05

Book Value$16.34 per share

Price / Book3.81

Profitability

EPS (Most Recent Fiscal Year)$3.03

Net Income$209.42 million

Net Margins9.15%

Return on Equity21.67%

Return on Assets15.50%

Miscellaneous

Employees20,400

Outstanding Shares65,240,000

Maximus (NYSE:MMS) Frequently Asked Questions

What is Maximus' stock symbol?

Maximus trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

How often does Maximus pay dividends? What is the dividend yield for Maximus?

Maximus announced a quarterly dividend on Wednesday, April 11th. Investors of record on Tuesday, May 15th will be given a dividend of $0.045 per share on Thursday, May 31st. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date of this dividend is Monday, May 14th. View Maximus' Dividend History.

How were Maximus' earnings last quarter?

Maximus Inc. (NYSE:MMS) announced its quarterly earnings results on Thursday, May, 10th. The health services provider reported $0.82 EPS for the quarter, missing analysts' consensus estimates of $0.84 by $0.02. The health services provider earned $612.79 million during the quarter, compared to the consensus estimate of $617.97 million. Maximus had a return on equity of 21.67% and a net margin of 9.15%. The firm's revenue for the quarter was down 1.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.80 earnings per share. View Maximus' Earnings History.

What guidance has Maximus issued on next quarter's earnings?

Maximus updated its FY18 earnings guidance on Thursday, May, 10th. The company provided earnings per share (EPS) guidance of $3.30-3.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.49. The company issued revenue guidance of $2.4-2.44 billion, compared to the consensus revenue estimate of $2.50 billion.

What price target have analysts set for MMS?

3 analysts have issued 1 year price objectives for Maximus' stock. Their predictions range from $64.00 to $81.00. On average, they expect Maximus' share price to reach $69.50 in the next year. View Analyst Ratings for Maximus.

Who are some of Maximus' key competitors?

Some companies that are related to Maximus include TSYS (TSS), Worldpay (WP), MSCI (MSCI), CoStar Group (CSGP), Broadridge Financial Solutions (BR), MercadoLibre (MELI), Akamai Technologies (AKAM), Cielo (CIOXY), Alliance Data (ADS), Nielsen (NLSN), Zillow (Z), Zillow (ZG), Grubhub (GRUB), Western Union (WU) and CDK Global (CDK).

Who are Maximus' key executives?

Maximus' management team includes the folowing people:

Mr. Bruce L. Caswell, Pres, CEO & Director (Age 51)
Mr. Richard J. Nadeau, CFO & Treasurer (Age 63)
Mr. David R. Francis, Gen. Counsel & Sec. (Age 57)
Mr. Mark S. Andrekovich, Chief of Human Capital and Pres of Tax & Employer Services (Age 56)
Mr. Kelly L. Clark, Chief Information Officer

Has Maximus been receiving favorable news coverage?

News articles about MMS stock have been trending somewhat positive recently, according to Accern Sentiment. The research group identifies positive and negative news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Maximus earned a news impact score of 0.14 on Accern's scale. They also gave news headlines about the health services provider an impact score of 45.87 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.

Who are Maximus' major shareholders?

Maximus' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.51%), Victory Capital Management Inc. (5.20%), Bamco Inc. NY (4.27%), Van Berkom & Associates Inc. (1.84%), Northern Trust Corp (1.69%) and Mondrian Investment Partners LTD (1.42%). Company insiders that own Maximus stock include Anne K Altman, Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Richard John Nadeau, Russell A Beliveau and Wellington E Webb. View Institutional Ownership Trends for Maximus.

Which major investors are selling Maximus stock?

MMS stock was sold by a variety of institutional investors in the last quarter, including Bamco Inc. NY, Boston Partners, Schwab Charles Investment Management Inc., WCM Investment Management CA, Comerica Bank, Elk Creek Partners LLC, Alambic Investment Management L.P. and Envestnet Asset Management Inc.. Company insiders that have sold Maximus company stock in the last year include Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Insider Buying and Selling for Maximus.

Which major investors are buying Maximus stock?

MMS stock was purchased by a variety of institutional investors in the last quarter, including P2 Capital Partners LLC, Thompson Siegel & Walmsley LLC, Mondrian Investment Partners LTD, BlackRock Inc., Handelsbanken Fonder AB, Wells Fargo & Company MN, Prudential Financial Inc. and Mackay Shields LLC. Company insiders that have bought Maximus stock in the last two years include Anne K Altman and Richard John Nadeau. View Insider Buying and Selling for Maximus.

How do I buy shares of Maximus?

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Maximus' stock price today?

One share of MMS stock can currently be purchased for approximately $62.24.

How big of a company is Maximus?

Maximus has a market capitalization of $4.06 billion and generates $2.45 billion in revenue each year. The health services provider earns $209.42 million in net income (profit) each year or $3.03 on an earnings per share basis. Maximus employs 20,400 workers across the globe.

How can I contact Maximus?

Maximus' mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]

MarketBeat Community Rating for Maximus (MMS)

Community Ranking:		2.6 out of 5 ( )
Outperform Votes:		308 (Vote Outperform)
Underperform Votes:		280 (Vote Underperform)
Total Votes:		588

MarketBeat's community ratings are surveys of what our community members think about Maximus and other stocks. Vote "Outperform" if you believe MMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Maximus (NYSE:MMS) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

3 Wall Street analysts have issued ratings and price targets for Maximus in the last 12 months. Their average twelve-month price target is $69.50, suggesting that the stock has a possible upside of 11.66%. The high price target for MMS is $81.00 and the low price target for MMS is $64.00. There are currently 3 hold ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Hold
Consensus Rating Score:	2.00	2.00	2.00	2.00
Ratings Breakdown:	0 Sell Rating(s) 3 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 4 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 4 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 5 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$69.50	$65.50	$65.50	$62.60
Price Target Upside:	11.66% upside	2.47% upside	2.47% upside	1.06% downside

Maximus (NYSE:MMS) Consensus Price Target History

Price Target History for Maximus (NYSE:MMS)

Maximus (NYSE:MMS) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/11/2018	Canaccord Genuity	Lower Price Target	Hold ➝ Hold	$65.00 ➝ $64.00	Low
5/8/2018	First Analysis	Upgrade	Equal ➝ Weight	$73.00 ➝ $81.00	High
2/8/2018	Maxim Group	Reiterated Rating	Hold ➝ Hold	$66.00 ➝ $69.00	Low
9/3/2017	Robert W. Baird	Initiated Coverage	Neutral		Low
5/25/2017	KeyCorp	Reiterated Rating	Overweight ➝ Sector Weight		High
5/5/2017	Jefferies Group	Downgrade	Buy ➝ Hold	$63.00 ➝ $64.00	Low
1/17/2017	Avondale Partners	Reiterated Rating	Market Outperform ➝ Market Perform	$58.00	N/A
11/15/2016	Sidoti	Downgrade	Buy ➝ Neutral	$55.00	N/A
11/9/2016	Raymond James	Downgrade	Outperform ➝ Market Perform		N/A
5/24/2016	Wells Fargo	Reiterated Rating	Buy		N/A

(Data available from 5/20/2016 forward)

Maximus (NYSE:MMS) Earnings History and Estimates Chart

Earnings by Quarter for Maximus (NYSE:MMS)

Maximus (NYSE:MMS) Earnings Estimates

2018 EPS Consensus Estimate: $3.29

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	2	$0.78	$0.79	$0.79
Q2 2018	3	$0.83	$0.86	$0.85
Q3 2018	3	$0.79	$0.86	$0.83
Q4 2018	3	$0.78	$0.85	$0.82
Q1 2019	1	$0.79	$0.79	$0.79

Maximus (NYSE MMS) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/10/2018	Q2 2018	$0.84	$0.82	$617.97 million	$612.79 million	View	N/A
2/8/2018	Q1 2018	$0.77	$0.78	$624.36 million	$623.10 million	View	N/A
11/9/2017	Q4 2017	$0.77	$0.81	$606.86 million	$620.90 million	View	N/A
8/3/2017	Q3 2017	$0.76	$0.79	$614.12 million	$600.40 million	View	Listen
5/4/2017	Q2 2017	$0.78	$0.80	$620.24 million	$622.00 million	View	Listen
2/9/2017	Q117	$0.63	$0.71	$599.98 million	$607.60 million	View	Listen
11/10/2016	Q416	$0.72	$0.7680	$610.65 million	$623.10 million	View	N/A
8/4/2016	Q316	$0.71	$0.75	$625.62 million	$617.10 million	View	N/A
5/5/2016	Q216	$0.62	$0.66	$600.99 million	$606.50 million	View	N/A
2/4/2016	Q116	$0.47	$0.40	$573.17 million	$556.70 million	View	N/A
11/12/2015	Q415	$0.52	$0.53	$591.02 million	$578.70 million	View	Listen
8/6/2015	Q315	$0.64	$0.64	$550.61 million	$572.30 million	View	N/A
5/7/2015	Q215	$0.53	$0.60	$463.63 million	$481.80 million	View	N/A
2/5/2015	Q115	$0.58	$0.59	$465.97 million	$467.00 million	View	N/A
11/13/2014	Q414	$0.52	$0.53	$445.72 million	$435.40 million	View	N/A
8/7/2014	Q314	$0.50	$0.49	$418.70 million	$419.90 million	View	N/A
5/8/2014	Q214	$0.56	$0.59	$432.35 million	$439.00 million	View	N/A
2/6/2014	Q114	$0.42	$0.48	$392.86 million	$406.60 million	View	N/A
11/15/2013	Q413	$0.50	$0.51	$359.35 million	$384.30 million	View	Listen
8/8/2013	Q3 2013	$0.41	$0.41	$325.19 million	$334.30 million	View	Listen
5/9/2013	Q2 2013	$0.70	$0.72	$310.13 million	$326.40 million	View	Listen
2/7/2013	Q1 2013	$0.56	$0.63	$284.60 million	$286.30 million	View	Listen
11/15/2012	Q412	$0.57	$0.74	$266.27 million	$300.70 million	View	N/A
8/7/2012		$0.56	$0.62			View	N/A
5/3/2012		$0.46	$0.49			View	N/A
2/2/2012		$0.53	$0.51			View	N/A
11/10/2011		$0.60	$0.64			View	N/A
8/4/2011		$0.54	$0.56			View	N/A
5/5/2011		$0.96	$1.07			View	N/A
2/3/2011		$0.96	$0.99			View	N/A
11/11/2010	Q4 2010	$0.26	$0.27			View	N/A
8/5/2010	Q3 2010	$0.23	$0.23			View	N/A
5/6/2010	Q2 2010	$0.18	$0.20			View	N/A
2/4/2010	Q1 2010	$0.16	$0.21			View	N/A
11/12/2009	Q4 2009	$0.20	$0.20			View	N/A
8/6/2009	Q3 2009	$0.17	$0.17			View	N/A
5/7/2009	Q2 2009	$0.16	$0.17			View	N/A
2/4/2009	Q1 2009	$0.17	$0.17			View	N/A
11/13/2008	Q4 2008	($0.02)	$0.18			View	N/A
8/7/2008	Q3 2008	$0.18	$0.16			View	N/A
5/8/2008	Q2 2008	$0.16	$0.17			View	N/A
2/6/2008	Q1 2008	$0.13	$0.13			View	N/A

(Earnings results data provided by Zacks Investment Research)

Maximus (NYSE:MMS) Dividend Information

Maximus pays an annual dividend of $0.18 per share, with a dividend yield of 0.29%. MMS's next quarterly dividend payment will be made on Thursday, May 31. Maximus pays out 5.94% of its earnings out as a dividend.

Next Dividend:	5/31/2018
Annual Dividend:	$0.18
Dividend Yield:	0.29%
Dividend Growth:	-9.10% (3 Year Average)
Payout Ratio(s):	5.94% (Trailing 12 Months of Earnings) 5.56% (Based on This Year's Estimates) 5.08% (Based on Next Year's Estimates) 4.35% (Based on Cash Flow)
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for Maximus (NYSE:MMS)

Maximus (NYSE:MMS) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/11/2018	quarterly	$0.0450	0.27%	5/14/2018	5/15/2018	5/31/2018
1/11/2018	quarterly	$0.0450	0.25%	2/14/2018	2/15/2018	2/28/2018
10/12/2017	quarterly	$0.0450	0.28%	11/14/2017	11/15/2017	11/30/2017
7/11/2017	quarterly	$0.0450	0.29%	8/11/2017	8/15/2017	8/31/2017
4/11/2017	quarterly	$0.0450	0.31%	5/11/2017	5/15/2017	5/31/2017
1/11/2017	quarterly	$0.0450	0.31%	2/13/2017	2/15/2017	2/28/2017
10/19/2016	quarterly	$0.0450	0.33%	11/10/2016	11/15/2016	11/30/2016
7/12/2016	quarterly	$0.0450	0.3%	8/11/2016	8/15/2016	8/31/2016
4/19/2016	quarterly	$0.0450	0.34%	5/11/2016	5/13/2016	5/31/2016
1/12/2016	quarterly	$0.0450	0.33%	2/11/2016	2/16/2016	2/29/2016
10/8/2015	quarterly	$0.0450	0.28%	11/10/2015	11/13/2015	11/30/2015
7/6/2015	quarterly	$0.0450	0.28%	8/12/2015	8/14/2015	8/31/2015
4/7/2015	quarterly	$0.0450	0.27%	5/13/2015	5/15/2015	5/29/2015
1/13/2015	quarterly	$0.0450	0.32%	2/11/2015	2/13/2015	2/27/2015
1/13/2015	quarterly	$0.0450			2/13/2015	1/27/2015
10/8/2014	quarterly	$0.0450	0.45%	11/12/2014	11/14/2014	11/28/2014
7/8/2014	quarterly	$0.0450	0.42%	8/13/2014	8/15/2014	8/29/2014
4/8/2014	quarterly	$0.0450	0.42%	5/13/2014	5/15/2014	5/30/2014
1/13/2014	quarterly	$0.0450	0.41%	2/12/2014	2/14/2014	2/28/2014
10/8/2013	quarterly	$0.0450	0.4%	11/13/2013	11/15/2013	11/29/2013
7/10/2013	quarterly	$0.0450	0.5%	8/13/2013	8/15/2013	8/30/2013
4/18/2013	quarterly	$0.09	0.46%	5/13/2013	5/15/2013	5/31/2013
1/9/2013	quarterly	$0.09	0.55%	2/13/2013	2/15/2013	2/28/2013

(Data available from 1/1/2013 forward)

Maximus (NYSE MMS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.10%
Institutional Ownership Percentage: 97.11%

Insider Trading History for Maximus (NYSE:MMS)

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Maximus (NYSE MMS) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/2/2018	Russell A Beliveau	Director	Sell	1,000	$66.55	$66,550.00
2/22/2018	Richard A Montoni	CEO	Sell	30,000	$67.89	$2,036,700.00
2/20/2018	Richard A Montoni	CEO	Sell	10,000	$67.42	$674,200.00
2/13/2018	David Francis	General Counsel	Sell	3,600	$64.50	$232,200.00	10,017
1/2/2018	Russell A Beliveau	Director	Sell	1,000	$71.73	$71,730.00
12/15/2017	Mark Andrekovich	Insider	Sell	2,700	$72.00	$194,400.00	20,296
12/7/2017	Richard A Montoni	CEO	Sell	30,000	$69.25	$2,077,500.00
12/5/2017	Mark Andrekovich	Insider	Sell	5,000	$68.80	$344,000.00	22,996
12/5/2017	Richard A Montoni	CEO	Sell	10,000	$69.04	$690,400.00
11/30/2017	Raymond B Ruddy	Director	Sell	10,350	$68.89	$713,011.50
11/22/2017	Mark Andrekovich	Insider	Sell	5,594	$67.23	$376,084.62	27,996
11/17/2017	David Francis	General Counsel	Sell	1,373	$65.35	$89,725.55	13,617
11/15/2017	Russell A Beliveau	Director	Sell	1,500	$64.30	$96,450.00	40,329
11/13/2017	David Francis	General Counsel	Sell	3,900	$63.97	$249,483.00	15,090
10/5/2017	David Francis	General Counsel	Sell	3,000	$65.28	$195,840.00
9/27/2017	Raymond B Ruddy	Director	Sell	25,000	$65.12	$1,628,000.00	226,652
9/18/2017	Bruce Caswell	President	Sell	8,000	$63.28	$506,240.00	35,904
9/11/2017	Raymond B Ruddy	Director	Sell	25,000	$62.68	$1,567,000.00	227,552
9/5/2017	Bruce Caswell	President	Sell	8,000	$60.23	$481,840.00	35,904
8/18/2017	David Francis	General Counsel	Sell	2,000	$58.89	$117,780.00	13,716
8/17/2017	Richard A Montoni	CEO	Sell	29,203	$60.38	$1,763,277.14	549,215
8/16/2017	Bruce Caswell	President	Sell	8,000	$60.50	$484,000.00	35,904
8/16/2017	Raymond B Ruddy	Director	Sell	25,000	$60.39	$1,509,750.00	252,552
8/14/2017	Paul R Lederer	Director	Sell	2,200	$60.87	$133,914.00
8/10/2017	Bruce Caswell	President	Sell	8,000	$59.83	$478,640.00	35,904
7/27/2017	Bruce Caswell	President	Sell	8,000	$60.97	$487,760.00	35,904
7/14/2017	David Francis	General Counsel	Sell	1,000	$60.46	$60,460.00	15,715
7/12/2017	Bruce Caswell	President	Sell	8,000	$62.21	$497,680.00	35,904
6/23/2017	David Francis	General Counsel	Sell	1,000	$63.15	$63,150.00	16,715
6/16/2017	Bruce Caswell	President	Sell	8,000	$63.56	$508,480.00	35,904
6/9/2017	Mark Andrekovich	Insider	Sell	8,939	$64.01	$572,185.39	24,583
6/5/2017	Bruce Caswell	President	Sell	8,000	$63.48	$507,840.00	35,904
6/2/2017	David Francis	General Counsel	Sell	1,000	$62.70	$62,700.00	17,715
5/25/2017	Richard A Montoni	CEO	Sell	30,000	$62.81	$1,884,300.00	584,114
5/23/2017	Bruce Caswell	President	Sell	8,000	$62.76	$502,080.00	35,904
5/18/2017	Bruce Caswell	President	Sell	8,000	$61.79	$494,320.00	35,904
5/16/2017	Russell A Beliveau	Director	Sell	1,500	$63.82	$95,730.00	41,829
5/12/2017	David Francis	General Counsel	Sell	1,000	$63.14	$63,140.00	18,716
5/11/2017	Bruce Caswell	President	Sell	17,197	$62.47	$1,074,296.59	27,904
5/9/2017	Paul R Lederer	Director	Sell	8,210	$61.83	$507,624.30	51,984
4/20/2017	David Francis	General Counsel	Sell	1,500	$59.91	$89,865.00	19,716
3/31/2017	David Francis	General Counsel	Sell	1,500	$62.40	$93,600.00	21,216
3/31/2017	Raymond B Ruddy	Director	Sell	8,500	$62.57	$531,845.00	279,477
3/30/2017	Raymond B Ruddy	Director	Sell	9,500	$62.53	$594,035.00	286,052
3/10/2017	David Francis	General Counsel	Sell	1,500	$60.36	$90,540.00	22,716
3/9/2017	Richard A Montoni	CEO	Sell	30,000	$60.59	$1,817,700.00	614,114
2/21/2017	Mark Andrekovich	Insider	Sell	5,620	$58.86	$330,793.20	38,080
2/17/2017	David Francis	General Counsel	Sell	1,500	$59.08	$88,620.00	24,216
2/10/2017	Anne K Altman	Director	Buy	2,700	$56.04	$151,308.00	2,700
12/15/2016	David Francis	General Counsel	Sell	1,901	$55.00	$104,555.00	25,716
12/15/2016	Mark Andrekovich	Insider	Sell	2,455	$54.87	$134,705.85	39,513
11/25/2016	Richard A Montoni	CEO	Sell	25,000	$57.00	$1,425,000.00	641,114
11/17/2016	David Francis	General Counsel	Sell	2,000	$55.00	$110,000.00	27,616
11/11/2016	Richard John Nadeau	CFO	Buy	1,000	$50.10	$50,100.00	10,256
10/14/2016	David Francis	General Counsel	Sell	2,000	$55.00	$110,000.00	29,616
9/22/2016	Bruce Caswell	President	Sell	20,000	$56.99	$1,139,800.00	36,386
9/1/2016	David Francis	General Counsel	Sell	1,500	$58.69	$88,035.00	21,936
8/26/2016	Paul R Lederer	Director	Sell	500	$59.15	$29,575.00	74,674
8/25/2016	Richard A Montoni	CEO	Sell	25,000	$58.70	$1,467,500.00	620,282
8/18/2016	Bruce Caswell	President	Sell	30,000	$58.98	$1,769,400.00	39,386
8/1/2016	David Francis	General Counsel	Sell	1,500	$58.91	$88,365.00	23,436
7/14/2016	Raymond B Ruddy	Director	Sell	18,000	$60.00	$1,080,000.00	295,552
7/1/2016	David Francis	General Counsel	Sell	1,500	$55.07	$82,605.00	24,936
6/22/2016	Bruce Caswell	President	Sell	30,000	$56.34	$1,690,200.00	39,386
6/21/2016	Bruce Caswell	President	Sell	10,000	$56.59	$565,900.00	39,386
6/20/2016	Bruce Caswell	President	Sell	10,000	$55.56	$555,600.00	39,386
6/6/2016	Wellington E. Webb	Director	Sell	560	$56.95	$31,892.00
6/2/2016	Russell A Beliveau	Director	Sell	1,000	$57.47	$57,470.00	44,479
6/1/2016	David Francis	General Counsel	Sell	1,500	$56.83	$85,245.00	26,436
5/19/2016	Richard A Montoni	CEO	Sell	25,000	$54.02	$1,350,500.00	645,282
5/17/2016	Paul R Lederer	Director	Sell	6,750	$54.78	$369,765.00	75,174
3/1/2016	Russell A Beliveau	Director	Sell	1,000	$49.35	$49,350.00	44,479
12/1/2015	Russell A Beliveau	Director	Sell	1,000	$56.81	$56,810.00	45,579
11/18/2015	Peter Pond	Director	Buy	14,375	$52.27	$751,381.25	14,375
11/13/2015	Richard John Nadeau	CFO	Buy	1,000	$53.16	$53,160.00	6,889
10/9/2015	Bruce Caswell	President	Sell	20,000	$61.80	$1,236,000.00	29,386
9/1/2015	Russell A Beliveau	Director	Sell	1,000	$59.58	$59,580.00	46,579
8/20/2015	Richard A Montoni	CEO	Sell	25,000	$62.00	$1,550,000.00
8/13/2015	Bruce Caswell	President	Sell	20,000	$59.94	$1,198,800.00
7/24/2015	Bruce Caswell	President	Sell	20,000	$68.03	$1,360,600.00
6/17/2015	Bruce Caswell	President	Sell	20,000	$63.00	$1,260,000.00
6/16/2015	Bruce Caswell	President	Sell	7,000	$62.61	$438,270.00
6/15/2015	Bruce Caswell	President	Sell	7,000	$62.31	$436,170.00
5/13/2015	Bruce Caswell	President	Sell	20,000	$62.96	$1,259,200.00
4/22/2015	Bruce Caswell	President	Sell	6,000	$66.92	$401,520.00
4/21/2015	Bruce Caswell	President	Sell	7,000	$66.26	$463,820.00
4/20/2015	Bruce Caswell	President	Sell	7,000	$65.74	$460,180.00
3/16/2015	David Francis	General Counsel	Sell	2,300	$64.09	$147,407.00
3/16/2015	Marilyn R Seymann	Director	Sell	2,802	$63.00	$176,526.00
3/3/2015	Mark Andrekovich	Insider	Sell	3,722	$60.00	$223,320.00
3/2/2015	Russell A Beliveau	Director	Sell	1,000	$59.43	$59,430.00
2/26/2015	Mark Andrekovich	Insider	Sell	3,185	$60.00	$191,100.00
2/26/2015	Paul R Lederer	Director	Sell	1,275	$59.65	$76,053.75
2/19/2015	Paul R Lederer	Director	Sell	3,060	$59.08	$180,784.80
2/19/2015	Richard A Montoni	CEO	Sell	25,000	$58.89	$1,472,250.00
2/17/2015	Marilyn R Seymann	Director	Sell	2,806	$59.60	$167,237.60
2/12/2015	David Francis	General Counsel	Sell	3,100	$59.08	$183,148.00
2/6/2015	Mark Andrekovich	Insider	Sell	3,093	$60.00	$185,580.00
1/23/2015	Mark Andrekovich	Insider	Sell	10,000	$57.00	$570,000.00
1/15/2015	Marilyn R Seymann	Director	Sell	2,806	$56.00	$157,136.00
12/24/2014	Mark Andrekovich	Insider	Sell	10,000	$55.02	$550,200.00
12/15/2014	Marilyn R Seymann	Director	Sell	2,806	$51.38	$144,172.28
12/3/2014	Paul R Lederer	Director	Sell	1,300	$53.61	$69,693.00
12/1/2014	Russell A Beliveau	Director	Sell	1,000	$52.31	$52,310.00
11/20/2014	Richard A Montoni	CEO	Sell	25,000	$51.76	$1,294,000.00
11/18/2014	Paul R Lederer	Director	Sell	6,250	$52.09	$325,562.50
11/17/2014	Marilyn R Seymann	Director	Sell	2,806	$52.55	$147,455.30
11/14/2014	Mark Andrekovich	Insider	Sell	15,000	$52.78	$791,700.00
10/30/2014	David Francis	General Counsel	Sell	19,340	$46.50	$899,310.00
10/28/2014	Akbar Piloti	Insider	Sell	23,740	$45.00	$1,068,300.00
9/15/2014	Marilyn R Seymann	Director	Sell	2,806	$41.33	$115,971.98
9/2/2014	Russell A Beliveau	Director	Sell	1,000	$41.29	$41,290.00
8/18/2014	Marilyn R Seymann	Director	Sell	2,806	$40.05	$112,380.30
8/18/2014	Richard A Montoni	CEO	Sell	25,000	$40.04	$1,001,000.00
7/15/2014	Marilyn R Seymann	Director	Sell	2,806	$41.79	$117,262.74
7/3/2014	Bruce Caswell	Insider	Sell	25,000	$1,397.09	$34,927,250.00
6/16/2014	Marilyn R Seymann	Director	Sell	2,806	$42.34	$118,806.04
6/12/2014	Bruce Caswell	Insider	Sell	25,000	$43.31	$1,082,750.00
6/2/2014	Russell A Beliveau	Director	Sell	1,000	$44.38	$44,380.00
5/22/2014	Richard Montoni	CEO	Sell	24,000	$42.70	$1,024,800.00	626,200
5/21/2014	Bruce Caswell	Insider	Sell	25,000	$42.62	$1,065,500.00	1
5/13/2014	Russell Beliveau	Director	Sell	10,000	$43.23	$432,300.00	53,179
4/23/2014	Bruce Caswell	Insider	Sell	25,000	$42.50	$1,062,500.00	1
4/2/2014	Bruce Caswell	Insider	Sell	18,799	$44.67	$839,751.33	1
4/1/2014	Akbar Piloti	Insider	Sell	3,290	$45.00	$148,050.00	13,878
4/1/2014	Russell Beliveau	Director	Sell	1,000	$44.92	$44,920.00	63,179
2/28/2014	John Haley	Director	Sell	5,316	$48.81	$259,473.96
2/25/2014	Bruce Caswell	Insider	Sell	7,000	$48.11	$336,770.00	17,134
2/24/2014	Bruce Caswell	Insider	Sell	7,000	$47.30	$331,100.00	24,135
2/24/2014	David Francis	General Counsel	Sell	1,205	$47.76	$57,550.80	13,129
2/21/2014	Bruce Caswell	Insider	Sell	7,000	$47.17	$330,190.00	31,135
2/19/2014	Paul Lederer	Director	Sell	8,550	$47.01	$401,935.50	88,530
2/14/2014	Raymond Ruddy	Director	Sell	31,364	$46.96	$1,472,853.44	313,552
2/13/2014	Richard Montoni	CEO	Sell	24,000	$47.09	$1,130,160.00	633,750
2/12/2014	Raymond Ruddy	Director	Sell	31,364	$47.24	$1,481,635.36	344,916
2/7/2014	David Walker	CFO	Sell	58,405	$47.61	$2,780,662.05	17,189
2/6/2014	Mark Andrekovich	Insider	Sell	4,302	$50.01	$215,143.02	38,135
1/2/2014	Peter Pond	Director	Sell	12,746	$42.86	$546,293.56
12/23/2013	Mark Andrekovich	Insider	Sell	4,303	$43.68	$187,955.04	44,701
12/16/2013	Mark Andrekovich	Insider	Sell	2,705	$43.62	$117,992.10	50,036
12/11/2013	Paul Lederer	Director	Sell	1,700	$43.94	$74,698.00	97,081
12/6/2013	Akbar Piloti	Insider	Sell	3,277	$45.05	$147,628.85	13,878
12/2/2013	Peter Pond	Director	Sell	12,746	$45.55	$580,580.30
11/26/2013	Mark Andrekovich	Insider	Sell	2,921	$45.59	$133,168.39	52,855
11/1/2013	Peter Pond	Director	Sell	12,748	$47.84	$609,864.32
10/3/2013	David Francis	General Counsel	Sell	17,000	$46.32	$787,440.00	15,378
9/3/2013	Peter Pond	Director	Sell	12,748	$37.36	$476,265.28
8/1/2013	Peter Pond	Director	Sell	12,748	$37.64	$479,834.72
7/8/2013	Peter Pond	Director	Sell	12,748	$36.44	$464,537.12
7/1/2013	Russell A Beliveau	Director	Sell	1,000	$37.77	$37,770.00
5/23/2013	Richard A Montoni	CEO	Sell	18,612	$74.23	$1,381,568.76
5/16/2013	David Francis	General Counsel	Sell	2,200	$77.92	$171,424.00
4/11/2013	Richard A Montoni	CEO	Sell	21,098	$79.27	$1,672,438.46
10/3/2012	David Francis	General Counsel	Sell	12,000	$59.92	$719,040.00

(Data available from 1/1/2013 forward)

Maximus (NYSE MMS) News Headlines

Source:

Date	Headline
	Analysts Expect Maximus Inc. (MMS) Will Announce Earnings of $0.81 Per Share www.americanbankingnews.com - May 19 at 7:14 PM
	Q3 2018 EPS Estimates for Maximus Inc. Reduced by Analyst (MMS) www.americanbankingnews.com - May 18 at 7:56 AM
	Maximus (MMS) Rating Lowered to Hold at Zacks Investment Research www.americanbankingnews.com - May 16 at 3:23 PM
	Q4 2018 EPS Estimates for Maximus Inc. (MMS) Lifted by KeyCorp www.americanbankingnews.com - May 14 at 4:03 AM
	Research Analysts Offer Predictions for Maximus Inc.'s Q3 2018 Earnings (MMS) www.americanbankingnews.com - May 14 at 2:58 AM
	MAXIMUS Enters Oversold Territory (MMS) www.nasdaq.com - May 12 at 9:04 AM
	MAXIMUS' (MMS) CEO Bruce Caswell on Q2 2018 Results - Earnings Call Transcript seekingalpha.com - May 12 at 9:04 AM
	Maximus (MMS) Price Target Cut to $64.00 www.americanbankingnews.com - May 11 at 5:43 PM
	Edited Transcript of MMS earnings conference call or presentation 10-May-18 1:00pm GMT finance.yahoo.com - May 11 at 9:09 AM
	Maximus (MMS) Posts Earnings Results, Misses Estimates By $0.02 EPS www.americanbankingnews.com - May 10 at 4:31 PM
	Maximus (MMS) Raised to Buy at Zacks Investment Research www.americanbankingnews.com - May 10 at 4:23 PM
	Maximus (MMS) Updates FY18 Earnings Guidance www.americanbankingnews.com - May 10 at 9:21 AM
	BRIEF-Maximus Reports Q2 Earnings Per Share Of $0.84 www.reuters.com - May 10 at 8:52 AM
	Maximus: Fiscal 2Q Earnings Snapshot finance.yahoo.com - May 10 at 8:52 AM
	Can MAXIMUS Inc (NYSE:MMS) Continue To Outperform Its Industry? finance.yahoo.com - May 10 at 8:52 AM
	First Analysis Equities Analysts Raise Earnings Estimates for Maximus Inc. (MMS) www.americanbankingnews.com - May 9 at 9:06 AM
	Measures taken to prevent power outages on polling day, says Maximus www.msn.com - May 9 at 8:48 AM
	Don't forget your MyKad and tissues, Maximus says www.msn.com - May 9 at 8:48 AM
	First Week of MMS May 18th Options Trading www.nasdaq.com - May 9 at 8:48 AM
	Maximus (MMS) Upgraded to Weight by First Analysis www.americanbankingnews.com - May 8 at 2:28 PM
	$617.67 Million in Sales Expected for Maximus Inc. (MMS) This Quarter www.americanbankingnews.com - May 4 at 3:58 AM
	Maximus (MMS) Set to Announce Earnings on Thursday www.americanbankingnews.com - May 3 at 2:20 AM
	Maximus Inc. (MMS) Expected to Post Earnings of $0.84 Per Share www.americanbankingnews.com - May 2 at 9:48 AM
	Maximus Inc. (MMS) Receives Average Rating of "Hold" from Analysts www.americanbankingnews.com - April 26 at 1:42 PM
	MAXIMUS Schedules Fiscal 2018 Second Quarter Conference Call finance.yahoo.com - April 19 at 8:42 AM
	MAXIMUS Reaches Analyst Target Price www.nasdaq.com - April 18 at 5:22 PM
	MAXIMUS Contact Centers in Georgia and New Jersey Awarded by BenchmarkPortal finance.yahoo.com - April 18 at 8:43 AM
	Detailed Research: Economic Perspectives on Menlo Therapeutics, Potbelly, Maximus, Veeva, RLJ Lodging Trust, and Net Element — What Drives Growth in Today's Competitive Landscape finance.yahoo.com - April 18 at 8:43 AM
	Maximus (MMS) Rating Lowered to Sell at Zacks Investment Research www.americanbankingnews.com - April 17 at 9:47 PM
	Analysts Expect Maximus Inc. (MMS) Will Announce Quarterly Sales of $617.67 Million www.americanbankingnews.com - April 17 at 4:23 AM
	Maximus (MMS) Rating Lowered to Sell at BidaskClub www.americanbankingnews.com - April 16 at 8:06 PM
	Maximus (MMS) Upgraded at Zacks Investment Research www.americanbankingnews.com - April 15 at 11:11 PM
	Zacks: Analysts Expect Maximus Inc. (MMS) Will Announce Earnings of $0.84 Per Share www.americanbankingnews.com - April 15 at 7:15 AM
	Maximus (MMS) Stock Rating Lowered by Zacks Investment Research www.americanbankingnews.com - April 12 at 3:58 PM
	Maximus (MMS) Downgraded to Hold at Zacks Investment Research www.americanbankingnews.com - April 12 at 10:19 AM
	MAXIMUS Center for Health Literacy Honored with ClearMark Award of Distinction by the Center for Plain Language finance.yahoo.com - April 12 at 9:20 AM
	Maximus Inc. (MMS) Plans $0.05 Quarterly Dividend www.americanbankingnews.com - April 11 at 10:47 AM
	Insider Selling: Maximus Inc. (MMS) Director Sells 1,000 Shares of Stock www.americanbankingnews.com - April 4 at 1:29 PM
	MAXIMUS to Discuss Innovations in Long-Term Services and Supports and Streamlining Provider Enrollment and Credentialing at State Healthcare IT Connect Summit finance.yahoo.com - April 3 at 8:53 AM
	Maximus Inc. (MMS) Given Average Rating of "Hold" by Brokerages www.americanbankingnews.com - April 1 at 1:30 PM
	Maximus Inc. (MMS) Expected to Announce Quarterly Sales of $617.67 Million www.americanbankingnews.com - March 31 at 3:06 AM
	Maximus (MMS) Upgraded to Hold at Zacks Investment Research www.americanbankingnews.com - March 27 at 7:58 PM
	Did Maximus Resources Limited’s (ASX:MXR) Earnings Growth Outperform The Industry? finance.yahoo.com - March 21 at 9:36 AM
	Free Post Earnings Research Report: MAXIMUS’ Revenues Grew 3%; EPS Surged 25% finance.yahoo.com - March 14 at 6:35 PM
	Zacks: Analysts Expect MAXIMUS, Inc. (MMS) Will Announce Quarterly Sales of $617.67 Million www.americanbankingnews.com - March 14 at 6:48 AM
	MAXIMUS to Present at the Barclays Global Healthcare Conference March 15 finance.yahoo.com - March 8 at 8:52 AM
	MAXIMUS, Inc. (MMS) Given Consensus Rating of "Hold" by Analysts www.americanbankingnews.com - March 7 at 4:07 PM
	Financial Survey: MAXIMUS (MMS) & Higher One (ONE) www.americanbankingnews.com - March 6 at 3:52 PM
	MAXIMUS, Inc. (MMS) Stake Increased by California Public Employees Retirement System www.americanbankingnews.com - March 6 at 5:26 AM
	MAXIMUS, Inc. (MMS) Stake Lowered by Ranger Investment Management L.P. www.americanbankingnews.com - March 5 at 3:42 PM

Maximus (NYSE:MMS) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Maximus (NYSE:MMS) Income Statement, Balance Sheet and Cash Flow Statement

Maximus (NYSE MMS) Stock Chart for Sunday, May, 20, 2018

Loading chart…

This page was last updated on 5/20/2018 by MarketBeat.com Staff